NCEL
NewcelX Ltd.
Price Chart
Latest Quote
$3.54
+0.04 (+1.00%)
Current Price
| Previous Close | $3.50 |
| Open | $3.58 |
| Day High | $3.59 |
| Day Low | $3.33 |
| Volume | 5,158 |
Stock Information
| Shares Outstanding | 5.38M |
| Total Debt | $355K |
| Cash Equivalents | $2.20M |
| Net Income | $-8.30M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $19.06M |
| EPS (TTM) | $-2.16 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $17.08M |
| Income | $-8.30M |
| Book/sh | $-11.28 |
| Cash/sh | $0.41 |
| Employees | 9 |
Financial Ratios
| Quick Ratio | 0.58 |
| Current Ratio | 0.76 |
| Debt/Eq | 4.90 |
Returns & Margins
| ROA | -25.94% |
Ownership
| Insider Ownership | 64.38% |
| Institutional Ownership | 3.56% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -0.31 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.28 |
| SMA50 | $3.33 |
| SMA200 | $6.09 |
| RSI | 57.90 |
| ATR | 0.2609 |
| Shares Float | 2.61M |
| Short Float | 2.55% |
| Short Ratio | 1.04 |
| Rel Volume | 0.08 |
Performance History
| Week | +10.62% |
| Month | +11.32% |
| Quarter | +44.49% |
| 6 Months | +30.63% |
| YTD | +69.38% |
| Year | -85.31% |
| 3 Years | -99.09% |
| 5 Years | -99.72% |
| 10 Years | -99.69% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $3.54 | 5,400 |
| 2026-06-22 | $3.49 | 34,000 |
| 2026-06-18 | $3.31 | 15,300 |
| 2026-06-17 | $3.15 | 15,900 |
| 2026-06-16 | $3.21 | 4,800 |
| 2026-06-15 | $3.20 | 7,700 |
| 2026-06-12 | $3.23 | 11,900 |
| 2026-06-11 | $3.27 | 17,900 |
| 2026-06-10 | $3.17 | 24,800 |
| 2026-06-09 | $3.17 | 10,400 |
| 2026-06-08 | $3.24 | 39,600 |
| 2026-06-05 | $2.93 | 17,100 |
| 2026-06-04 | $3.15 | 22,800 |
| 2026-06-03 | $3.16 | 9,800 |
| 2026-06-02 | $3.32 | 10,000 |
| 2026-06-01 | $3.48 | 18,900 |
| 2026-05-29 | $3.52 | 27,000 |
| 2026-05-28 | $3.54 | 81,300 |
| 2026-05-27 | $3.45 | 916,200 |
| 2026-05-26 | $3.15 | 13,400 |
About NewcelX Ltd.
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.
đ° Latest News
EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug
Benzinga âĸ 2026-05-01T18:00:52Z
Despite NewcelX's Pullback, Insiders Still Gained âĒ136k
Simply Wall St. âĸ 2026-05-01T10:36:02Z
Owning 58% in NewcelX Ltd. (NASDAQ:NCEL) means that insiders are heavily invested in the company's future
Simply Wall St. âĸ 2025-11-01T13:10:42Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $6,008,000 | $5,044,000 | $239,000 | $78,036 |
| Total Expenses | $2,474,000 | $1,797,000 | $3,015,000 | $6,245,743 |
| Other Income Expense | $-88,000 | $-269,000 | $-7,902 | $7,378 |
| Net Non Operating Interest Income Expense | $-5,738,000 | $-5,131,000 | $-317,000 | $-255,675 |
| Total Other Finance Cost | $99,000 | $93,000 | $114,000 | $190,976 |
| Interest Expense Non Operating | $6,008,000 | $5,044,000 | $239,000 | $78,036 |
| Operating Expense | $2,474,000 | $1,797,000 | $3,015,000 | $6,245,743 |
| Selling And Marketing Expense | $0 | $0 | $81,000 | $84,847 |
| General And Administrative Expense | $1,348,000 | $805,000 | $1,326,000 | $1,791,146 |
| Other Non Operating Income Expenses | - | $79,938 | - | - |
| Rent Expense Supplemental | - | - | $21,863 | $40,295 |
| Other Operating Expenses | - | - | - | $40,295 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Net Interest Income | $-5,738,000 | $-5,131,000 | $-317,000 | $-255,675 |
| Interest Income | $369,000 | $6,000 | $36,000 | $13,337 |
| Normalized Income | $-8,212,000 | $-6,928,000 | $-3,332,000 | $-6,453,976 |
| Net Income From Continuing And Discontinued Operation | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Net Income Common Stockholders | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Net Income | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Net Income Including Noncontrolling Interests | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Net Income Continuous Operations | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Pretax Income | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,494,041 |
| Special Income Charges | $-88,000 | $-269,000 | $0 | $0 |
| Interest Income Non Operating | $369,000 | $6,000 | $36,000 | $13,337 |
| Operating Income | $-2,474,000 | $-1,797,000 | $-3,015,000 | $-6,245,743 |
| Total Operating Income As Reported | - | $-2,080,305 | $-2,907,831 | $-6,245,743 |
| Depreciation Amortization Depletion Income Statement | - | $189,716 | $92,458 | $91,941 |
| Depreciation And Amortization In Income Statement | - | $189,716 | $92,458 | $91,941 |
| Depreciation Income Statement | - | $189,716 | $92,458 | $91,941 |
| Gross Profit | - | $0 | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $-2.16 | $-2.43 | $-1.13 | $-2.59 |
| Basic EPS | $-2.16 | $-2.43 | $-1.13 | $-2.59 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $54 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,149,000 | $-1,471,000 | $-2,473,000 | $-5,872,872 |
| Total Unusual Items | $-88,000 | $-269,000 | $0 | $7,378 |
| Total Unusual Items Excluding Goodwill | $-88,000 | $-269,000 | $0 | $7,378 |
| Reconciled Depreciation | $55,000 | $413,000 | $620,000 | $550,511 |
| EBITDA (Bullshit earnings) | $-2,237,000 | $-1,740,000 | $-2,473,000 | $-5,865,494 |
| EBIT | $-2,292,000 | $-2,153,000 | $-3,093,000 | $-6,416,005 |
| Diluted Average Shares | $3,843,984 | $2,959,303 | $2,955,027 | $2,490,062 |
| Basic Average Shares | $3,843,984 | $2,959,303 | $2,955,027 | $2,490,062 |
| Diluted NI Availto Com Stockholders | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Restructuring And Mergern Acquisition | $88,000 | $269,000 | $0 | $0 |
| Research And Development | $1,126,000 | $992,000 | $1,608,000 | $4,277,809 |
| Selling General And Administration | $1,348,000 | $805,000 | $1,407,000 | $1,875,993 |
| Other Gand A | $1,348,000 | $805,000 | $1,326,000 | $515,040 |
| Otherunder Preferred Stock Dividend | - | $0 | $0 | $0 |
| Tax Provision | - | $-8,213 | $-52,683 | $-47,389 |
| Gain On Sale Of Security | - | $-47,361 | $-7,902 | $7,378 |
| Salaries And Wages | - | $508,099 | $747,307 | $1,235,812 |
| Rent And Landing Fees | - | - | $21,863 | $40,295 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-918,000 | $-7,996,000 | $-1,148,487 | $92,509 |
| Total Assets | $11,445,000 | $903,000 | $2,203,725 | $3,543,984 |
| Total Non Current Assets | $8,263,000 | $123,000 | $678,555 | $1,439,274 |
| Goodwill And Other Intangible Assets | $8,168,000 | $0 | - | - |
| Other Intangible Assets | $6,437,000 | - | - | - |
| Current Assets | $3,182,000 | $780,000 | $1,525,169 | $2,104,711 |
| Other Current Assets | $163,000 | - | - | - |
| Current Deferred Assets | $296,000 | $0 | - | - |
| Prepaid Assets | $522,000 | $130,000 | $14,224 | $69,523 |
| Cash Cash Equivalents And Short Term Investments | $2,201,000 | $650,000 | $1,094,487 | $1,813,848 |
| Cash And Cash Equivalents | $2,201,000 | $650,000 | $1,094,487 | $1,813,848 |
| Receivables | - | $68,440 | $416,458 | $221,339 |
| Other Receivables | - | $250,000 | $416,458 | $221,339 |
| Cash Financial | - | $2,372,000 | $1,094,487 | $674,518 |
| Other Non Current Assets | - | - | $162,790 | $162,599 |
| Cash Equivalents | - | - | $0 | $1,139,330 |
| Loans Receivable | - | - | - | $1,419 |
| Non Current Note Receivables | - | - | - | - |
| Accounts Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $355,000 | $2,665,000 | $2,623,080 | $2,023,553 |
| Current Debt And Capital Lease Obligation | $355,000 | $2,665,000 | $2,623,080 | $1,580,590 |
| Current Debt | $355,000 | $2,665,000 | $2,278,008 | $1,182,747 |
| Net Debt | - | $2,015,000 | $1,183,521 | - |
| Other Current Borrowings | - | $2,372,000 | $1,990,359 | $891,317 |
| Long Term Debt And Capital Lease Obligation | - | - | $834,000 | $442,963 |
| Long Term Debt | - | - | $834,000 | $0 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,195,000 | $8,899,000 | $3,352,211 | $3,451,476 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $5,005 | $462,259 |
| Current Liabilities | $4,195,000 | $8,899,000 | $3,347,206 | $2,989,217 |
| Current Deferred Liabilities | $1,674,000 | $42,000 | $0 | $0 |
| Current Deferred Taxes Liabilities | $1,674,000 | $0 | - | - |
| Payables And Accrued Expenses | $2,166,000 | $1,131,000 | $724,126 | $1,408,627 |
| Payables | $1,915,000 | $968,000 | $508,126 | $1,408,627 |
| Accounts Payable | $1,915,000 | $568,000 | $508,126 | $1,047,389 |
| Other Current Liabilities | - | $5,061,000 | - | - |
| Other Payable | - | $400,000 | $820,000 | $361,237 |
| Other Non Current Liabilities | - | - | $3,634,000 | - |
| Equity | ||||
| Common Stock Equity | $7,246,000 | $-7,996,000 | $-1,148,487 | $92,509 |
| Preferred Stock Equity | $4,000 | - | - | - |
| Total Equity Gross Minority Interest | $7,250,000 | $-7,996,000 | $-1,148,487 | $92,509 |
| Stockholders Equity | $7,250,000 | $-7,996,000 | $-1,148,487 | $92,509 |
| Gains Losses Not Affecting Retained Earnings | $-1,845,000 | $-1,094,000 | $3,594,289 | $3,545,687 |
| Retained Earnings | $-84,891,000 | $-76,591,000 | $-65,233,517 | $-66,855,562 |
| Other Equity Interest | - | $6,351,000 | $1,737,218 | $4,235,528 |
| Other Equity Adjustments | - | $4,014,422 | $3,594,289 | $3,545,687 |
| Other | ||||
| Ordinary Shares Number | $4,797,505 | $2,960,744 | $2,960,745 | $2,570,316 |
| Share Issued | $4,797,505 | $2,960,744 | $2,960,745 | $2,570,316 |
| Tangible Book Value | $-922,000 | $-7,996,000 | $-1,148,487 | $92,509 |
| Invested Capital | $7,601,000 | $-5,331,000 | $1,129,521 | $1,275,255 |
| Working Capital | $-1,013,000 | $-8,119,000 | $-1,822,037 | $-884,506 |
| Total Capitalization | $7,250,000 | $-7,996,000 | $-1,148,487 | $92,509 |
| Foreign Currency Translation Adjustments | $-1,845,000 | $-1,094,000 | - | - |
| Additional Paid In Capital | $93,691,000 | $69,505,000 | $57,649,027 | $58,133,655 |
| Capital Stock | $295,000 | $184,000 | $1,104,496 | $1,033,201 |
| Common Stock | $291,000 | $184,000 | $1,104,496 | $1,033,201 |
| Preferred Stock | $4,000 | $0 | - | - |
| Current Deferred Revenue | $0 | $42,000 | $0 | $0 |
| Line Of Credit | $355,000 | $293,000 | $287,648 | $291,430 |
| Current Accrued Expenses | $251,000 | $163,000 | $216,000 | $361,237 |
| Goodwill | $1,731,000 | - | - | - |
| Net PPE | $95,000 | $123,000 | $515,765 | $1,276,674 |
| Accumulated Depreciation | $-1,632,000 | $-1,347,000 | $-2,909,939 | $-3,204,597 |
| Gross PPE | $1,727,000 | $1,470,000 | $3,425,704 | $4,481,271 |
| Leases | $152,000 | $134,000 | $126,702 | $137,911 |
| Other Properties | $1,122,000 | $970,000 | $1,043,911 | $1,889,614 |
| Machinery Furniture Equipment | $453,000 | $366,000 | $478,097 | $530,931 |
| Properties | $0 | $0 | $0 | $0 |
| Employee Benefits | - | $0 | $5,005 | $19,296 |
| Non Current Pension And Other Postretirement Benefit Plans | - | $0 | $19,000 | $19,296 |
| Buildings And Improvements | - | $7,233,000 | $1,776,993 | $1,922,815 |
| Capital Lease Obligations | - | - | $345,073 | $840,806 |
| Long Term Capital Lease Obligation | - | - | $0 | $442,963 |
| Current Capital Lease Obligation | - | - | $345,073 | $397,843 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-2,774,000 | $-1,072,000 | $-3,450,000 | $-5,855,846 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,766,000 | $-1,066,000 | $-3,444,000 | $-5,674,234 |
| Cash Flow From Continuing Operating Activities | $-2,766,000 | $-1,066,000 | $-3,444,000 | $-5,674,234 |
| Operating Gains Losses | $64,000 | $130,000 | $96,000 | $568 |
| Investing Activities | ||||
| Capital Expenditure | $-8,000 | $-6,000 | $-6,000 | $-181,612 |
| Investing Cash Flow | $1,700,000 | $-6,000 | $103,000 | $-186,152 |
| Cash Flow From Continuing Investing Activities | $1,700,000 | $-6,000 | $103,000 | $-186,152 |
| Net Other Investing Changes | - | $169,184 | $-11,854 | $-4,540 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $1,607,000 | $1,553,632 |
| Financing Cash Flow | $2,629,000 | $450,000 | $2,849,000 | $1,056,754 |
| Cash Flow From Continuing Financing Activities | $2,629,000 | $450,000 | $2,849,000 | $1,056,754 |
| Net Common Stock Issuance | $0 | $0 | $1,607,000 | $1,553,632 |
| Common Stock Issuance | $0 | $0 | $1,607,000 | $1,553,632 |
| Other | ||||
| Issuance Of Debt | $290,000 | $450,000 | $1,242,000 | $0 |
| End Cash Position | $2,201,000 | $650,000 | $1,316,000 | $1,813,848 |
| Beginning Cash Position | $650,000 | $1,316,000 | $1,974,000 | $6,609,818 |
| Effect Of Exchange Rate Changes | $-12,000 | $-44,000 | $-166,000 | $7,662 |
| Changes In Cash | $1,563,000 | $-622,000 | $-492,000 | $-4,803,632 |
| Proceeds From Stock Option Exercised | $2,339,000 | $0 | $0 | $1,091,941 |
| Net Issuance Payments Of Debt | $290,000 | $450,000 | $1,242,000 | $0 |
| Net Long Term Debt Issuance | $290,000 | $450,000 | $1,242,000 | $0 |
| Long Term Debt Issuance | $290,000 | $450,000 | $1,242,000 | $0 |
| Net Business Purchase And Sale | $1,708,000 | $0 | $0 | - |
| Sale Of Business | $1,708,000 | $0 | $0 | - |
| Net PPE Purchase And Sale | $-8,000 | $-6,000 | $103,000 | $-181,612 |
| Sale Of PPE | $0 | $0 | $109,000 | $0 |
| Purchase Of PPE | $-8,000 | $-6,000 | $-6,000 | $-181,612 |
| Change In Working Capital | $-1,070,000 | $736,000 | $-766,000 | $-280,931 |
| Change In Payables And Accrued Expense | $-869,000 | $415,000 | $-601,000 | $-70,942 |
| Change In Payable | $-869,000 | $415,000 | $-601,000 | $-70,942 |
| Change In Account Payable | $-869,000 | $415,000 | $-601,000 | $144,154 |
| Change In Prepaid Assets | $-201,000 | $321,000 | $-165,000 | - |
| Other Non Cash Items | $5,720,000 | $4,644,000 | $-211,000 | $384,506 |
| Stock Based Compensation | $765,000 | $208,000 | $149,000 | $230,420 |
| Depreciation Amortization Depletion | $55,000 | $413,000 | $620,000 | $550,511 |
| Depreciation And Amortization | $55,000 | $413,000 | $620,000 | $550,511 |
| Pension And Employee Benefit Expense | $64,000 | $130,000 | $130,000 | $568 |
| Gain Loss On Sale Of PPE | $0 | $0 | $-34,000 | $0 |
| Net Income From Continuing Operations | $-8,300,000 | $-7,197,000 | $-3,332,000 | $-6,446,652 |
| Repayment Of Debt | - | $-358,626 | $0 | $-496,879 |
| Long Term Debt Payments | - | $-358,626 | $0 | $-496,879 |
| Interest Paid Cfo | - | $-134,964 | $-77,971 | $-65,267 |
| Change In Other Working Capital | - | $41,612 | - | $-112,656 |
| Change In Other Current Assets | - | $41,612 | $0 | $-112,656 |
| Change In Receivables | - | $317,836 | $-160,683 | $-97,333 |
| Deferred Tax | - | $-35,863 | $-52,683 | $-47,389 |
| Deferred Income Tax | - | $-35,863 | $-52,683 | $-47,389 |
| Depreciation | - | $418,580 | $602,692 | $550,511 |
| Net Short Term Debt Issuance | - | - | - | - |
| Changes In Account Receivables | - | - | - | - |
Fetched: 2026-06-18